194 related articles for article (PubMed ID: 2519884)
1. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
[TBL] [Abstract][Full Text] [Related]
2. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis.
Wallace JL
Can J Physiol Pharmacol; 1988 Apr; 66(4):422-5. PubMed ID: 3167675
[TBL] [Abstract][Full Text] [Related]
3. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
5. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
[TBL] [Abstract][Full Text] [Related]
7. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
Fernandez-Gallardo S; Cano E; Braquet P; Sanchez Crespo M
Int J Immunopharmacol; 1988; 10(4):353-60. PubMed ID: 3139574
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
9. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P
Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
11. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist.
Doly M; Bonhomme B; Braquet P; Chabrier PE; Meyniel G
Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784
[TBL] [Abstract][Full Text] [Related]
12. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
13. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.
Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P
Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526
[TBL] [Abstract][Full Text] [Related]
14. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether.
Bureau M; Joseph D; Vargaftig BB
Prostaglandins; 1987 Jan; 33(1):37-50. PubMed ID: 3035615
[TBL] [Abstract][Full Text] [Related]
15. The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.
Al-Jarallah A; Oriowo M
PLoS One; 2017; 12(5):e0170792. PubMed ID: 28493876
[TBL] [Abstract][Full Text] [Related]
16. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
Gálvez J; Garrido M; Merlos M; Torres MI; Zarzuelo A
Br J Pharmacol; 2000 Aug; 130(8):1949-59. PubMed ID: 10952687
[TBL] [Abstract][Full Text] [Related]
17. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021.
Acker G; Hecquet F; Etienne A; Braquet P; Mencia-Huerta JM
Prostaglandins; 1988 Feb; 35(2):233-41. PubMed ID: 3129758
[TBL] [Abstract][Full Text] [Related]
19. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis.
Bourgain RH; Andries R; Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196
[TBL] [Abstract][Full Text] [Related]
20. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.
Bourgain RH; Maes L; Braquet P; Andries R; Touqui L; Braquet M
Prostaglandins; 1985 Aug; 30(2):185-97. PubMed ID: 3931178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
